Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Other Non-Current Assets came in at $1.0 million in Q1 2026, up 79.9% year-on-year from $565023.3 in Q1 2025, and up 3.5% quarter-over-quarter from $982168.3 in Q4 2025.

Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 79.9% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 79.9% increase from a year earlier, with the FY2025 full-year figure at $946810.9, up 74.99% from the prior year.
  • Other Non-Current Assets rose to $1.0 million in Q1 2026 per OCS's latest filing, from $982168.3 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2026 and bottomed at $76813.6 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $196831.2 (2024), against an average of $411139.4.
  • Across the five-year window, Other Non-Current Assets increased 25.66% in 2024 and surged 466.87% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $76813.6 in 2022, then jumped by 30.62% to $100334.5 in 2023, then surged by 441.55% to $543364.4 in 2024, then soared by 80.76% to $982168.3 in 2025, then increased by 3.5% to $1.0 million in 2026.
  • Per Business Quant, the three latest OCS Other Non-Current Assets figures stand at $1.0 million (Q1 2026), $982168.3 (Q4 2025), and $665058.3 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 63.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.02 Mn
Dec 31, 2025 982,168.29
Sep 30, 2025 665,058.26
Jun 30, 2025 643,805.49
Mar 31, 2025 565,023.27
Dec 31, 2024 543,364.40
Sep 30, 2024 183,518.95
Jun 30, 2024 196,831.24
Mar 31, 2024 99,674.36
Dec 31, 2023 100,334.55
Sep 30, 2023 146,047.68
Jun 30, 2023 125,675.84
Dec 31, 2022 76,813.62